Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emdogain in Autotransplantation of Closed-apex Teeth
NCT06250088Phase 4Recruiting
- Sponsor
- Complutense University of Madrid
- Start
- Mar 2024
- Primary completion
- Jun 2025
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of enamel matrix derivative in tooth loss, sponsored by Complutense University of Madrid. Started Mar 2024; status: recruiting.
02
Drugs
enamel matrix derivative
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT06250088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06250088.